JPS62201889A - カルバモイルオキシメチルカルバペネム類 - Google Patents

カルバモイルオキシメチルカルバペネム類

Info

Publication number
JPS62201889A
JPS62201889A JP61275681A JP27568186A JPS62201889A JP S62201889 A JPS62201889 A JP S62201889A JP 61275681 A JP61275681 A JP 61275681A JP 27568186 A JP27568186 A JP 27568186A JP S62201889 A JPS62201889 A JP S62201889A
Authority
JP
Japan
Prior art keywords
ester
azetidinone
acid
methyl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61275681A
Other languages
English (en)
Japanese (ja)
Inventor
Shoichiro Ageo
上尾 庄一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of JPS62201889A publication Critical patent/JPS62201889A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP61275681A 1985-11-19 1986-11-19 カルバモイルオキシメチルカルバペネム類 Pending JPS62201889A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60-260731 1985-11-19
JP26073185 1985-11-19

Publications (1)

Publication Number Publication Date
JPS62201889A true JPS62201889A (ja) 1987-09-05

Family

ID=17351968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61275681A Pending JPS62201889A (ja) 1985-11-19 1986-11-19 カルバモイルオキシメチルカルバペネム類

Country Status (10)

Country Link
JP (1) JPS62201889A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR870004984A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU6534786A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE905784A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1283416C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH671580A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3639542C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2590256B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2183236B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1195842B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292191A1 (en) * 1987-05-21 1988-11-23 Merck & Co. Inc. 2-(Substituted methyl)-1-alkylcarbapenem derivatives
US6143885A (en) * 1997-08-27 2000-11-07 Merck & Co., Inc. Preparation of beta-methyl carbapenem intermediates
JP2001514169A (ja) * 1997-08-27 2001-09-11 メルク エンド カムパニー インコーポレーテッド β−メチルカルバペネム中間体の製造

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
EP0184844A1 (en) * 1984-12-13 1986-06-18 Merck & Co. Inc. 1-Methylcarbapenems having a 2-position substituent joined through an alkylenethio bridge

Also Published As

Publication number Publication date
CH671580A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-09-15
DE3639542A1 (de) 1987-05-21
GB8627656D0 (en) 1986-12-17
GB2183236B (en) 1989-04-12
IT8667861A0 (it) 1986-11-19
FR2590256B1 (fr) 1989-12-22
GB2183236A (en) 1987-06-03
IT1195842B (it) 1988-10-27
CA1283416C (en) 1991-04-23
DE3639542C2 (de) 1995-07-13
BE905784A (fr) 1987-03-16
AU6534786A (en) 1987-05-21
KR870004984A (ko) 1987-06-04
FR2590256A1 (fr) 1987-05-22

Similar Documents

Publication Publication Date Title
JPH0470315B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0745500B2 (ja) 1−メチルカルバペネム誘導体及びその製法
JPS6056160B2 (ja) β−ラクタマ−ゼ阻害剤としてのペニシラン酸1,1−ジオキシド
CA1276014C (en) 2-heterocyclylthio penems
HU193429B (en) Process for production of peneme derivatives of 2-/alkyl-tio/-6-/hydroxi-alkyl/
JPS62201889A (ja) カルバモイルオキシメチルカルバペネム類
WO2002094829A1 (fr) Compose de carbapenem
KR840000722B1 (ko) 카바펜암과 카바펜-2-엠의 제조방법
JPH03128383A (ja) フェナシル化ピリジニオチオセファロスポリン
JPH03120280A (ja) ハロメチルカルバペネム化合物の製法
KR0177844B1 (ko) 항균성 페넴화합물
PL144812B1 (en) Process for preparing novel bis-esters of dicarboxylic acids
JP2973126B2 (ja) 新規なペナム誘導体およびその塩
JP3523664B2 (ja) 新規なペナム誘導体またはその塩
JPS6028981A (ja) ジオキソラニルペネムカルボン酸誘導体
US4349551A (en) Penicillin derivatives and compositions containing them
JPS6145993B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0798821B2 (ja) 2−(9−フルオレノニル)−カルバペネム
JP2832742B2 (ja) カルバペネム誘導体
US5492903A (en) Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
KR970011389B1 (ko) 신규 카바페넴계 항생제 및 그의 제조방법
JPH0260679B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR100246949B1 (ko) 신규 카바페넴계 항생제
KR100246950B1 (ko) 신규 카바페넴계 항생제 및 그의 제조방법
KR100246947B1 (ko) 신규 카바페넴계 항생제